|
EAF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.71679999999763E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.36529999999969E-05 |
| Normal-vs-Stage2 |
9.071900E-02 |
| Normal-vs-Stage3 |
9.219100E-03 |
| Normal-vs-Stage4 |
4.353400E-04 |
| Stage1-vs-Stage2 |
5.567400E-01 |
| Stage1-vs-Stage3 |
8.354000E-01 |
| Stage1-vs-Stage4 |
4.792000E-01 |
| Stage2-vs-Stage3 |
7.047200E-01 |
| Stage2-vs-Stage4 |
2.706400E-01 |
| Stage3-vs-Stage4 |
3.550800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.79460000000664E-05 |
| Normal-vs-AfricanAmerican |
7.393300E-04 |
| Normal-vs-Asian |
1.499760E-01 |
| Caucasian-vs-AfricanAmerican |
9.470600E-01 |
| Caucasian-vs-Asian |
6.831600E-01 |
| AfricanAmerican-vs-Asian |
6.964600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.75110000003131E-06 |
| Normal-vs-Female |
4.703600E-02 |
| Male-vs-Female |
3.944300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.408800E-04 |
| Normal-vs-Extreme_Weight |
1.24229999998171E-06 |
| Normal-vs-Obese |
1.724420E-03 |
| Normal-vs-Extreme_Obese |
4.250200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.564600E-01 |
| Normal_Weight-vs-Obese |
4.042200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.202400E-01 |
| Extreme_Weight-vs-Obese |
1.235020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.336200E-01 |
| Obese-vs-Extreme_Obese |
6.434400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.320700E-03 |
| Normal-vs-Age(41-60Yrs) |
7.376900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.16629999999496E-05 |
| Normal-vs-Age(81-100Yrs) |
3.301000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.965600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.952400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.331600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.395400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.317600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.594800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.59221999999071E-05 |
| Normal-VS-Type2 PRCC |
8.517000E-03 |
| Normal-VS-KIRP CIMP |
2.089200E-01 |
| Normal-VS-Unclassified PRCC |
4.486400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.342400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.699200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.171600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.936800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.665600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.847800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.27229999999668E-05 |
| Normal-vs-N1 |
4.596300E-03 |
| Normal-vs-N2 |
1.616370E-02 |
| N0-vs-N1 |
4.384000E-01 |
| N0-vs-N2 |
8.224400E-01 |
| N1-vs-N2 |
5.318600E-01 |
|
|
